Zacks Investment Research on MSN
BAX raises 2026 outlook as strong Q2 growth offsets margin pressure
Baxter International Inc. BAX raised its 2026 sales and adjusted earnings outlook after second-quarter results exceeded ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Add Yahoo as a preferred source to see more of our stories on Google. Martin Bax: travelled the world working to improve standards of care, understanding and treatment of children with disabilities - ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
StockStory.org on MSN
3 healthcare stocks we keep off our radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those ...
Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickinson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results